Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Culture, Health & Sexuality
|
February 4, 2021
Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention
Gabriella Y Jackson, Caroline K Darlington, Hong Van Tieu, et al.
Developmental Biology
|
December 8, 2004
Integrin alpha4beta1 function is required for cell survival in developing retina
Sergiu T Leu, Susan A L Jacques, Kevin L Wingerd, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
September 28, 2011
Chagas disease in European countries: the challenge of a surveillance system
L Basile, J M Jansa, Y Carlier, et al.
Plos One
|
July 18, 2022
Alterations in the molecular composition of COVID-19 patient urine, detected using Raman spectroscopic/computational analysis
John L Robertson, Ryan S Senger, Janine Talty, et al.
JAMA Network Open
|
July 5, 2023
Perspectives About Racism and Patient-Clinician Communication Among Black Adults With Serious Illness
Crystal E Brown, Arisa R Marshall, Cyndy R Snyder, et al.
Journal of Medicinal Chemistry
|
July 26, 2002
Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agents
Nathan J P Dubree, Dean R Artis, Georgette Castanedo, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2002
Solid-phase synthesis of dual alpha4beta1/alpha4beta7 integrin antagonists: two scaffolds with overlapping pharmacophores
Georgette M Castanedo, Fredrick C Sailes, Nathan J P Dubree, et al.
Journal of Medicinal Chemistry
|
October 28, 1997
Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents
D Y Jackson, C Quan, D R Artis, et al.
Blood Cancer Journal
|
May 30, 2015
A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies
S Y Kim, J-W Theunissen, J Balibalos, et al.
Molecular Pharmaceutics
|
September 23, 2015
Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs
Christopher R Behrens, Edward H Ha, Lawrence L Chinn, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Culture, Health & Sexuality
|
February 4, 2021
Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention
Gabriella Y Jackson, Caroline K Darlington, Hong Van Tieu, et al.
Developmental Biology
|
December 8, 2004
Integrin alpha4beta1 function is required for cell survival in developing retina
Sergiu T Leu, Susan A L Jacques, Kevin L Wingerd, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
September 28, 2011
Chagas disease in European countries: the challenge of a surveillance system
L Basile, J M Jansa, Y Carlier, et al.
Plos One
|
July 18, 2022
Alterations in the molecular composition of COVID-19 patient urine, detected using Raman spectroscopic/computational analysis
John L Robertson, Ryan S Senger, Janine Talty, et al.
JAMA Network Open
|
July 5, 2023
Perspectives About Racism and Patient-Clinician Communication Among Black Adults With Serious Illness
Crystal E Brown, Arisa R Marshall, Cyndy R Snyder, et al.
Journal of Medicinal Chemistry
|
July 26, 2002
Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agents
Nathan J P Dubree, Dean R Artis, Georgette Castanedo, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2002
Solid-phase synthesis of dual alpha4beta1/alpha4beta7 integrin antagonists: two scaffolds with overlapping pharmacophores
Georgette M Castanedo, Fredrick C Sailes, Nathan J P Dubree, et al.
Journal of Medicinal Chemistry
|
October 28, 1997
Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents
D Y Jackson, C Quan, D R Artis, et al.
Blood Cancer Journal
|
May 30, 2015
A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies
S Y Kim, J-W Theunissen, J Balibalos, et al.
Molecular Pharmaceutics
|
September 23, 2015
Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs
Christopher R Behrens, Edward H Ha, Lawrence L Chinn, et al.
Page
of 8